UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 179 filers reported holding UNIQURE NV in Q4 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $21 | -30.0% | 3,400 | -64.2% | 0.00% | -50.0% |
Q2 2023 | $30 | -68.8% | 9,500 | -23.4% | 0.00% | -60.0% |
Q1 2023 | $96 | -85.0% | 12,400 | -88.3% | 0.01% | -81.5% |
Q4 2022 | $641 | -99.9% | 105,672 | +15.9% | 0.05% | +38.5% |
Q3 2022 | $562,000 | +20.6% | 91,212 | +3.3% | 0.04% | +18.2% |
Q2 2022 | $466,000 | -4.9% | 88,262 | +42.9% | 0.03% | +26.9% |
Q1 2022 | $490,000 | -30.0% | 61,762 | -33.6% | 0.03% | -10.3% |
Q4 2021 | $700,000 | +238.2% | 93,062 | +48.9% | 0.03% | +222.2% |
Q3 2021 | $207,000 | +47.9% | 62,480 | +568.4% | 0.01% | +50.0% |
Q2 2021 | $140,000 | -26.3% | 9,348 | -14.6% | 0.01% | -33.3% |
Q1 2021 | $190,000 | +46.2% | 10,948 | +65.4% | 0.01% | +50.0% |
Q4 2020 | $130,000 | -43.2% | 6,618 | -33.6% | 0.01% | -53.8% |
Q3 2020 | $229,000 | -84.5% | 9,960 | -82.1% | 0.01% | -86.7% |
Q2 2020 | $1,482,000 | -1.7% | 55,600 | +1.6% | 0.10% | +27.3% |
Q1 2020 | $1,507,000 | +7.2% | 54,701 | +98.9% | 0.08% | -10.5% |
Q4 2019 | $1,406,000 | +388.2% | 27,502 | -21.3% | 0.09% | +230.8% |
Q3 2019 | $288,000 | -41.5% | 34,960 | +46.3% | 0.03% | -43.5% |
Q2 2019 | $492,000 | +39.0% | 23,900 | +51.3% | 0.05% | +24.3% |
Q1 2019 | $354,000 | -46.4% | 15,800 | -47.5% | 0.04% | -40.3% |
Q4 2018 | $660,000 | -45.3% | 30,100 | -38.6% | 0.06% | -26.2% |
Q3 2018 | $1,206,000 | +35.5% | 48,991 | +45.8% | 0.08% | +18.3% |
Q2 2018 | $890,000 | +429.8% | 33,600 | +233.8% | 0.07% | +407.1% |
Q1 2018 | $168,000 | -0.6% | 10,066 | +1.0% | 0.01% | +100.0% |
Q4 2017 | $169,000 | +16800.0% | 9,966 | +1561.0% | 0.01% | – |
Q3 2017 | $1,000 | -80.0% | 600 | -77.0% | 0.00% | – |
Q2 2017 | $5,000 | -68.8% | 2,608 | -27.9% | 0.00% | -100.0% |
Q1 2017 | $16,000 | -61.0% | 3,617 | -58.5% | 0.00% | 0.0% |
Q4 2016 | $41,000 | -48.1% | 8,708 | -29.5% | 0.00% | -75.0% |
Q3 2016 | $79,000 | -17.7% | 12,360 | -23.5% | 0.00% | -20.0% |
Q2 2016 | $96,000 | -59.1% | 16,160 | -44.8% | 0.01% | -68.8% |
Q1 2016 | $235,000 | +170.1% | 29,260 | +56.1% | 0.02% | +220.0% |
Q4 2015 | $87,000 | – | 18,750 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |